Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 24/10/20061 min de leitura
Draft Guidance for Industry and Food and Drug Administration Staff; Total Product Life Cycle for Portable Invasive Blood Glucose Monitoring Systems; Availability
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled "Draft Guidance for Industry and FDA Staff: Total Product Life Cycle for Portable Invasive Blood Glucose Monitoring Systems." This draft guidance provides FDA's recommendations concerning portable invasive blood glucose monitoring systems (BGMSs).
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →